Proteasome Inhibitor Carbobenzoxy-L-Leucyl-L-Leucyl-L-Leucinal (MG132) Enhances Therapeutic Effect of Paclitaxel on Breast Cancer by Inhibiting Nuclear Factor (NF)-κB Signaling
Authors:
Open Access
- 15 January 2018
- journal article
- research article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 24, 294-304
Abstract
BACKGROUND:Carbobenzoxy-L-leucyl-L-leucyl-L-leucinal (MG132), a peptide aldehyde proteasome inhibitor, can inhibit tumor progression by inactivating nuclear factor (NF)-κB signaling. Paclitaxel (PTX) is part of a routine regimen for the treatment of...Keywords
This publication has 39 references indexed in Scilit:
- The ubiquitin proteasome system and efficacy of proteasome inhibitors in diseasesInternational Journal of Rheumatic Diseases, 2012
- The Rel/NF-κB Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-x LMolecular and Cellular Biology, 2000
- NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced ApoptosisMolecular and Cellular Biology, 1999
- The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNFalpha -induced apoptosisGenes & Development, 1999
- Taxol selectively blocks microtubule dependent NF-κB activation by phorbol ester via inhibition of IκBα phosphorylation and degradationOncogene, 1999
- NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 ActivationScience, 1998
- Role of I Bα Ubiquitination in Signal-induced Activation of NF- B in VivoJournal of Biological Chemistry, 1996
- Critical Role for Lysines 21 and 22 in Signal-induced, Ubiquitin-mediated Proteolysis of IkB-αJournal of Biological Chemistry, 1996
- Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.Proceedings of the National Academy of Sciences, 1995
- Use of Taxol (Paclitaxel) in Breast CancerOncology, 1994